secwatch.observer — SEC 8-K summary
======================================

Issuer:     LB PHARMACEUTICALS INC (LBRX)
CIK:        0001691082
Form:       8-K
Filed at:   2026-06-09T20:05:22+00:00
Accession:  0001193125-26-263724
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

LB Pharma shareholders elect three Class I directors, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Class I directors elected: Robert A. Lenz (20,059,577 for), Rebecca Luse (18,530,680), Ran Nussbaum (18,748,511).
- Broker non-votes of 3,216,636 on each director election.
- Ratification of BDO USA as auditor for FY 2026: 23,275,974 for, 5,490 against, 2,753 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1691082/000119312526263724/0001193125-26-263724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1691082/000119312526263724/d138757d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-263724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer